Many of the patients I see on long-term benzodiazepines were first prescribed them decades ago — for anxiety, insomnia, or a rough patch after a loss — and nobody ever circled back to ask whether the prescription still made sense. By the time someone is in their 70s on daily alprazolam, the risk-benefit picture has changed dramatically, even if the dose has not. If you or a family member has been on one of these medications for years, this article is for you.
Why benzodiazepines are on the "avoid" list for older adults
The American Geriatrics Society Beers Criteria — the most influential list of medications to avoid in older adults — has flagged benzodiazepines for decades. The reasons are specific and backed by consistent data:
- Falls and hip fractures. Benzodiazepines roughly double fall risk in adults over 65. Hip fractures in this age group carry a 20–30% one-year mortality.
- Cognitive decline and delirium. Even "low" doses impair memory and attention. Patients are often misdiagnosed with early dementia that improves — sometimes dramatically — after tapering.
- Motor vehicle crashes. Comparable to driving with a blood alcohol of 0.05–0.10%.
- Respiratory depression, especially when combined with opioids, gabapentin, or alcohol.
- Dependence. Physical dependence develops within weeks of daily use. It is not a character issue — it is pharmacology.
The FDA's benzodiazepine drug information page lays out these risks in detail, and the NIA guidance on safe medication use in older adults reinforces why routine medication review matters as we age.
When benzodiazepines ARE appropriate
This is important: the goal is not zero benzodiazepine prescriptions. They remain the right tool for:
- Short-term (2–4 week) treatment of acute, severe anxiety
- Alcohol withdrawal
- Certain seizure disorders
- End-of-life and palliative care
- Procedural sedation
The problem is chronic daily use in older adults, especially for indications where better, safer options now exist.
Never stop cold turkey
Abrupt discontinuation of a benzodiazepine, especially at higher doses or after long use, can cause withdrawal seizures — a genuine medical emergency. The taper has to be planned, patient-led, and slow.
A typical framework your physician may use:
- Stabilize first. Confirm current dose, frequency, and any supplementation. Switch short-acting agents like alprazolam or lorazepam to a longer-acting equivalent (such as clonazepam or diazepam) when the taper is expected to be difficult. Longer-acting agents produce a smoother withdrawal curve.
- Reduce by 10–25% every 2–4 weeks. Slower is almost always better. Some patients need 6–12 months.
- Hold reductions when symptoms flare. Deprescribing is not a race; plateaus are expected.
- Watch for the last 25%, which is often the hardest — receptors are most sensitive at low doses. Tapering by 5–10% at this stage is reasonable.
- Support with a clear replacement plan for the underlying symptom (see below).
What to replace them with
For insomnia, cognitive behavioral therapy for insomnia (CBT-I) is the gold standard — it outperforms every sleep medication in head-to-head trials and the benefits persist after treatment ends. It is also covered by Medicare and widely available via telehealth. For selected older patients, low-dose trazodone is a reasonable short-term bridge. If sleep apnea is on the differential — and it often is — our St. Pete senior sleep apnea guide is a good place to start.
For chronic anxiety, SSRIs or SNRIs (sertraline, escitalopram, duloxetine) are first-line for generalized anxiety disorder and major depressive disorder. They take 4–8 weeks to work but do not cause dependence, falls, or cognitive impairment. CBT is equally effective and often combined with medication. Our St. Pete mental health and anxiety guide covers what local resources are available.
For both, lifestyle matters more than patients expect: regular exercise (even 20 minutes most days), caffeine reduction after noon, morning light exposure, mindfulness and breathing practice, and a consistent bed/wake schedule. Pair this with attention to fall prevention and broader healthy-aging preventative care, and you have a much sturdier foundation than any pill alone.
When to involve addiction medicine
If a patient has escalated dose without medical guidance, combines benzodiazepines with opioids or alcohol, has had seizures during prior taper attempts, or is using non-prescribed pills, a specialist referral is appropriate. This is not a moral judgment — it is recognition that complex tapers benefit from dedicated expertise, and SAMHSA's national helpline is available any time for referrals and support.
The good news
Patients who complete a benzodiazepine taper frequently report better sleep, sharper thinking, fewer falls, and improved mood within 2–3 months of the last dose. Many describe it as "getting themselves back." It takes patience and a strong clinician partnership, but it is genuinely achievable.
Let's build a plan together
If you or a loved one has been on a benzodiazepine for more than a few months, let's look at it together. We will map out a realistic taper, set up the replacement strategy, and monitor you closely. Schedule a visit and we'll start the conversation — no judgment, just a plan.
